...
首页> 外文期刊>Molecular pain >Repeated activation of delta opioid receptors counteracts nerve injury-induced TNF-α up-regulation in the sciatic nerve of rats with neuropathic pain
【24h】

Repeated activation of delta opioid receptors counteracts nerve injury-induced TNF-α up-regulation in the sciatic nerve of rats with neuropathic pain

机译:阿片类阿片受体的重复激活抵消了神经性疼痛大鼠坐骨神经中神经损伤诱导的TNF-α上调

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Despite mu opioid receptor agonists are the cornerstones of moderate-to-severe acute pain treatment, their effectiveness in chronic pain conditions is controversial. In contrast to mu opioid receptor agonists, a number of studies have reported the effectiveness of delta opioid receptor agonists on neuropathic pain strengthening the idea that delta opioid receptors gain importance when chronic pain develops. Among other effects, it has been shown that delta opioid receptor activation in optic nerve astrocytes inhibits tumor necrosis factor-α-mediated inflammation in response to severe hypoxia. Considering the involvement of tumor necrosis factor-α in the development and maintenance of neuropathic pain, with this study we sought to correlate the effect of delta opioid receptor agonist on the development of mechanical allodynia to tumor necrosis factor-α expression at the site of nerve injury in rats subjected to chronic constriction injury of the sciatic nerve. To this aim, we measured the levels of tumor necrosis factor-α in the sciatic nerve of rats with neuropathic pain after repeated injections with a delta opioid receptor agonist. Results obtained demonstrated that repeated administrations of the delta opioid receptor agonist SNC80 (10?mg/kg, i.p. for seven consecutive days) significantly inhibited the development of mechanical allodynia in rats with neuropathic pain and that the improvement of neuropathic symptom was timely related to the reduced expression of tumor necrosis factor-α in the rat sciatic nerve. We demonstrated also that when treatment with the delta opioid receptor agonist was suspended both allodynia and tumor necrosis factor-α up-regulation in the sciatic nerve of rats with neuropathic pain were restored. These results show that persistent delta opioid receptor activation significantly attenuates neuropathic pain and negatively regulates sciatic nerve tumor necrosis factor-α expression in chronic constriction injury rats.
机译:尽管μ阿片受体激动剂是中度至重度急性疼痛治疗的基石,但它们在慢性疼痛情况下的有效性仍存在争议。与μ阿片受体激动剂相反,许多研究报告了δ阿片受体激动剂对神经性疼痛的有效性,从而强化了当慢性疼痛发生时δ阿片受体变得重要的观点。除其他作用外,已显示视神经星形胶质细胞中的δ阿片样物质受体活化抑制了对严重缺氧的肿瘤坏死因子-α介导的炎症。考虑到肿瘤坏死因子-α参与神经性疼痛的发生和维持,本研究旨在将δ阿片受体激动剂对机械性异常性疼痛发展的影响与神经部位的肿瘤坏死因子-α表达相关联大鼠遭受坐骨神经慢性压迫性损伤。为此,我们在反复注射δ阿片受体激动剂后,测量了神经性疼痛大鼠坐骨神经中的肿瘤坏死因子-α水平。获得的结果表明,重复给药δ阿片受体激动剂SNC80(10?mg / kg,腹腔注射连续7天)可显着抑制神经性疼痛大鼠的机械性异常性疼痛的发展,并且神经性症状的改善与该症状的发生有关。降低大鼠坐骨神经中肿瘤坏死因子-α的表达我们还证明,当暂停使用阿片类阿片受体激动剂的治疗时,异常神经痛大鼠的坐骨神经中的异常性疼痛和肿瘤坏死因子-α上调均得以恢复。这些结果表明,在慢性收缩性损伤大鼠中,持续的δ阿片样物质受体活化显着减轻了神经性疼痛,并负面调节了坐骨神经肿瘤坏死因子-α的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号